Skip to main content

Logout

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Metabolic

Cardiovascular

Respiratory
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

See all products

Products

See all products
Resources
Contact
Logout

Boehringer Ingelheim

CLINICAL STUDIES

fue_micardis as protective as ramipril_ct2_as_1.jpg

PDF

Micardis Vs. Other ARBS

PC-SA-101588 (April 2026 )

Download Opens in new tab

fue_micardis as protective as ramipril_ct2_as_3.jpg

PDF

MICARDIS® (TELMISARTAN) HAS PLACEBO-LIKE TOLERABILITY

PC-SA-101593 (April 2026 )

Download Opens in new tab

fue_micardis as protective as ramipril_ct2_as_4.jpg

PDF

MICARDIS® (TELMISARTAN) HAS LOWEST RENAL EXCRETION OF CLINICALLY AVAILABLE ARBs

PC-SA-101592 (April 2026 )

Download Opens in new tab

Pagination

Load More

Home
Clinical studies

Sitemap

Therapeutic Area

Resources
- Videos
- Clinical studies

BI

Site Map
Privacy
Terms of use
Contact

.

© 2010-2023 Boehringer Ingelheim International GmbH. All rights reserved. PC-SA-102596